Presentation TCT 2012 No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents. Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg January 03, 2012
Presentation Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR November 09, 0018
Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017
Presentation Quality-of-life Outcomes After TAVR in an Unselected Population Presenter: Suzanne Arnold February 06, 0017